Willis Investment Counsel’s Clorox CLX Stock Holding History

Willis Investment Counsel’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.8M	Buy	230,000 +25,400	+12%	+$2.88M	1.3%	34
2025 Q4	$20.6M	Sell	204,600 -27,800	-12%	-$3.02M	1.07%	40
2025 Q3	$28.7M	Buy	232,400 +9,494	+4%	+$1.18M	1.57%	22
2025 Q2	$26.8M	Buy	222,906 +20,228	+10%	+$2.7M	1.57%	21
2025 Q1	$29.8M	Buy	202,678 +16,893	+9%	+$2.58M	2.01%	14
2024 Q4	$30.2M	Buy	185,785 +819	+0.4%	+$134K	1.98%	12
2024 Q3	$30.1M	Buy	184,966 +597	+0.3%	+$88.5K	1.96%	16
2024 Q2	$25.2M	Buy	184,369 +132	+0.1%	+$18.3K	1.74%	21
2024 Q1	$28.2M	Buy	184,237 +576	+0.3%	+$86K	1.94%	16
2023 Q4	$26.2M	Sell	183,661 -755	-0.4%	-$101K	1.84%	16
2023 Q3	$24.2M	Sell	184,416 -17,170	-9%	-$2.61M	1.83%	16
2023 Q2	$32.1M	Buy	201,586 +222	+0.1%	+$35.8K	2.09%	10
2023 Q1	$31.9M	Buy	201,364 +755	+0.4%	+$113K	2.08%	9
2022 Q4	$28.2M	Buy	200,609 +1,732	+0.9%	+$246K	1.8%	16
2022 Q3	$25.5M	Sell	198,877 -19,270	-9%	-$2.78M	1.85%	16
2022 Q2	$30.8M	Sell	218,147 -37,799	-15%	-$5.4M	1.88%	16
2022 Q1	$35.6M	Buy	255,946 +21,412	+9%	+$3.28M	1.88%	17
2021 Q4	$40.9M	Sell	234,534 -12,575	-5%	-$2.1M	2.15%	13
2021 Q3	$40.9M	Buy	247,109 +39,997	+19%	+$6.89M	2.34%	11
2021 Q2	$37.3M	Buy	207,112 +8,553	+4%	+$1.56M	2.2%	14
2021 Q1	$38.3M	Buy	198,559 +55,739	+39%	+$10.7M	2.33%	12
2020 Q4	$28.8M	Buy	+142,820	New	+$29.6M	1.97%	17
2020 Q1	–	Sell	-44,020	Closed	-$6.76M	–	110
2019 Q4	$6.76M	Buy	+44,020	New	+$6.58M	0.44%	63
2019 Q3	–	Sell	-91,833	Closed	-$14.1M	–	101
2019 Q2	$14.1M	Buy	91,833 +66,813	+267%	+$10.2M	0.95%	52
2019 Q1	$4.01M	Sell	25,020 -9,700	-28%	-$1.5M	0.28%	90
2018 Q4	$5.35M	Sell	34,720 -44,200	-56%	-$6.89M	0.4%	84
2018 Q3	$11.9M	Buy	78,920 +9,900	+14%	+$1.41M	0.82%	58
2018 Q2	$9.34M	Buy	69,020 +10,800	+19%	+$1.33M	0.69%	65
2018 Q1	$7.75M	Buy	58,220 +700	+1%	+$94K	0.6%	71
2017 Q4	$8.56M	Buy	57,520 +800	+1%	+$109K	0.6%	73
2017 Q3	$7.48M	Buy	56,720 +1,300	+2%	+$175K	0.54%	77
2017 Q2	$7.38M	Buy	+55,420	New	+$7.48M	0.56%	79
2016 Q2	–	Sell	-2,020	Closed	-$255K	–	126
2016 Q1	$255K	Sell	2,020 -17,445	-90%	-$2.22M	0.02%	124
2015 Q4	$2.47M	Sell	19,465 -10,935	-36%	-$1.36M	0.22%	106
2015 Q3	$3.51M	Buy	+30,400	New	+$3.41M	0.34%	96

Other funds holding CLX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Willis Investment Counsel's CLX Position: Q1 2026 in Review

Willis Investment Counsel increased its Clorox (CLX) stake by 12% in Q1 2026, buying an estimated $2.88M and bringing the position to 230,000 shares worth $23.8M. The position accounts for 1.3% of the portfolio, ranked #34.

Willis Investment Counsel first reported a position in CLX in Q3 2015 and has held it in 35 quarters since. The position peaked at $40.9M in Q3 2021. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

Willis Investment Counsel held 230,000 shares of Clorox worth $23.8M as of Q1 2026.
Willis Investment Counsel bought 25,400 Clorox shares in Q1 2026, an estimated $2.88M.
Clorox made up 1.3% of Willis Investment Counsel's portfolio in Q1 2026, its #34 holding.
Willis Investment Counsel first reported a position in Clorox in Q3 2015 and has held it in 35 quarters since.
Willis Investment Counsel's Clorox position peaked at $40.9M in Q3 2021.
1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Willis Investment Counsel's 13F filing for Q1 2026, filed 5 May 2026.